Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Darshit Ashok Dave, Ainembabazi Provia, Nana Nakiddu, Erin Sodawasser, Katrina Harper, John Ssenkusu, Sabrina Kitaka, Melanie Nicol, Joseph Musaazi & Christine Sekaggya. (2022) Nutritional status and its associated factors among HIV adolescents on second line regimen at Pediatric Infectious Diseases Clinic in Uganda. Journal of HIV/AIDS & Social Services 21:1, pages 63-75.
Read now
Read now
Articles from other publishers (26)
Athmanand Anchi, Pavan Kumar P, Rajesh G. Kalkhambkar, Ravi S. Naik, Abdel Majid A. Adam, Moamen S. Refat & Amnah Mohammed Alsuhaibani. (2023) Synthesis of Symmetrical Biaryls by Copper‐Catalysed Homocoupling of Aryltriazenes in Guanidinium Ionic Liquid. ChemistrySelect 8:37.
Crossref
Crossref
Trinette Fernandes, Vainav Patel, Clara Aranha, Shilpa Velhal, Munira Momin, Madhura Mulkutkar & Sujata Sawarkar. (2023) pH-triggered polymeric nanoparticles in gel for preventing vaginal transmission of HIV and unintended pregnancy. European Journal of Pharmaceutics and Biopharmaceutics 191, pages 219-234.
Crossref
Crossref
Alfredo A. HinayJr.Jr., Kyosuke Kanai, Akeno Tsuneki-Tokunaga, Mizuki Komatsu, Elizabeth O. Telan & Seiji Kageyama. (2022) In Vitro Susceptibility of HIV Isolates with High Growth Capability to Antiretroviral Drugs. International Journal of Molecular Sciences 23:23, pages 15380.
Crossref
Crossref
Panagiotis Zagaliotis, Anthi Petrou, George Mystridis, Athina Geronikaki, Ioannis Vizirianakis & Thomas Walsh. (2022) Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling. International Journal of Molecular Sciences 23:14, pages 8006.
Crossref
Crossref
Shannon Turvey, Lynora Saxinger & Andrew Mason. (2022) Apples to Apples? A Comparison of Real-World Tolerability of Antiretrovirals in Patients with Human Immunodeficiency Virus Infection and Patients with Primary Biliary Cholangitis. Viruses 14:3, pages 516.
Crossref
Crossref
Jagruti Desai & Hetal Thakkar. (2022) Mechanistic evaluation of lymphatic targeting efficiency of Atazanavir sulfate loaded lipid nanocarriers: In-vitro and in-vivo studies. Journal of Drug Delivery Science and Technology 68, pages 103090.
Crossref
Crossref
Regis Kreitchmann, Alice Stek, Brookie M. Best, Edmund Capparelli, JiaJia Wang, David Shapiro, Nahida Chakhtoura, Mark Mirochnick & Ahizechukwu C. Eke. (2022) Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens. Contraception 105, pages 67-74.
Crossref
Crossref
Luis F. Pereira, Ofole U. Mgbako, Johanna Paulino-Woolridge, Miguel Edgar Cardoso Figueiredo & Tessa del Carmen. 2022. HIV Psychiatry. HIV Psychiatry
391
413
.
Otávio Augusto Chaves, Carolina Q. Sacramento, André C. Ferreira, Mayara Mattos, Natalia Fintelman-Rodrigues, Jairo R. Temerozo, Leonardo Vazquez, Douglas Pereira Pinto, Gabriel P. E. da Silveira, Laís Bastos da Fonseca, Heliana Martins Pereira, Aluana Santana Carlos, Joana C. d’Avila, João P. B. Viola, Robson Q. Monteiro, Patrícia T. Bozza, Hugo Caire Castro-Faria-Neto & Thiago Moreno L. Souza. (2021) Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo. Pharmaceuticals 15:1, pages 21.
Crossref
Crossref
Anupam Jana, V. Ravichandiran & Sharada Prasanna Swain. (2021)
Application of organometallic catalysts for the synthesis of
o
-tolyl benzonitrile, a key starting material for sartans
. New Journal of Chemistry 45:38, pages 17753-17771.
Crossref
Crossref
Márió Miczi, Ádám Diós, Beáta Bozóki, József Tőzsér & János András Mótyán. (2021) Development of a Bio-Layer Interferometry-Based Protease Assay Using HIV-1 Protease as a Model. Viruses 13:6, pages 1183.
Crossref
Crossref
Siyamak Shahab, Masoome Sheikhi, Radwan Alnajjar, Sultan Al Saud, Maksim Khancheuski & Aleksandra Strogova. (2021) DFT investigation of atazanavir as potential inhibitor for 2019-nCoV coronavirus M protease. Journal of Molecular Structure 1228, pages 129461.
Crossref
Crossref
İrfan Aygün, Mehmet Kaya & Reda Alhajj. (2020) Identifying side effects of commonly used drugs in the treatment of Covid 19. Scientific Reports 10:1.
Crossref
Crossref
Sleiman Alhajj & Salih Gencer. (2020) Investigating Side Effects of Existing Drugs Used in Covid-19 Treatment. Investigating Side Effects of Existing Drugs Used in Covid-19 Treatment.
Nitin B. Charbe, Flavia C. Zacconi, Nikhil Amnerkar, B. Ramesh, Murtaza M. Tambuwala & Emilio Clementi. (2019) Bio-analytical Assay Methods used in Therapeutic Drug Monitoring of Antiretroviral Drugs-A Review. Current Drug Therapy 14:1, pages 16-57.
Crossref
Crossref
Pedro Campos, Alberto Ortiz & Karina Soto. (2016) HIV and kidney diseases: 35 years of history and consequences. Clinical Kidney Journal 9:6, pages 772-781.
Crossref
Crossref
Maria Teresa Pereira, Lia Ferreira, Ana Aboim Horta & André Couto de Carvalho. (2016) Exogenous Cushing's syndrome as a result of ritonavir–budesonide interaction – A case report. HIV & AIDS Review 15:2, pages 91-93.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
687
736
.
Mohamed Mahdi, Zsófia Szojka, János Mótyán & József Tőzsér. (2015) Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System. Viruses 7:12, pages 6152-6162.
Crossref
Crossref
Jessica Milian, Allison B. Goldfine, Jonah P. Zuflacht, Caitlin Parmer & Joshua A. Beckman. (2015) Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 diabetes mellitus. Acta Diabetologica 52:4, pages 709-715.
Crossref
Crossref
Dongwei Guo, Gang Zhang, Tadeusz A. Wysocki, Beata J. Wysocki, Harris A. Gelbard, Xin-Ming Liu, JoEllyn M. McMillan & Howard E. Gendelman. (2014) Endosomal Trafficking of Nanoformulated Antiretroviral Therapy Facilitates Drug Particle Carriage and HIV Clearance. Journal of Virology 88:17, pages 9504-9513.
Crossref
Crossref
Changfu Cheng, Sunanda Vedananda, Lijun Wu, Scott Harbeson, Virginia Braman & Roger Tung. (2013) Revealing the metabolic sites of atazanavir in human by parallel administrations of D‐atazanavir analogs. Journal of Mass Spectrometry 48:9, pages 1019-1031.
Crossref
Crossref
Changfu Cheng, Richard Gallegos, Gary Bridson, Lijun Wu, Scott Harbeson, Robert Zelle & Roger Tung. (2013)
Identification and structural elucidation of
in vitro
metabolites of atazanavir by HPLC and tandem mass spectrometry
. Journal of Mass Spectrometry 48:6, pages 640-650.
Crossref
Crossref
Emiliano BissioGustavo D. Lopardo. (2013) Incidence of Hyperbilirubinemia and Jaundice Due to Atazanavir in a Cohort of Hispanic Patients. AIDS Research and Human Retroviruses 29:3, pages 415-417.
Crossref
Crossref
Atul K. PatelKetan K. Patel, Eknath Naik, Jingyi Duan, Rajiv Ranjan, Jagdish K. Patel & Hamisu M. Salihu. (2011) Comparison of the Effectiveness of Low-Dose Indinavir/Ritonavir (IDV/r)- versus Atazanavir/Ritonavir (ATV/r)-Based Generic Antiretroviral Therapy in NNRTI-Experienced HIV-1-Infected Patients in India. Journal of the International Association of Physicians in AIDS Care 10:2, pages 111-118.
Crossref
Crossref
M Fabbiani, S Di Giambenedetto, E Ragazzoni, M Colafigli, M Prosperi, R Cauda, P Navarra & A De Luca. (2010) Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection. HIV Medicine 11:5, pages 326-333.
Crossref
Crossref